Selank Research Overview
An overview of Selank, a synthetic immunomodulatory peptide, and its role in neurological and immune research.
Scientific background / literature overview only. Discussion of published research does not describe the intended use of Novex Peptide products.
Introduction
> **Research Context Notice** — This article summarises published scientific literature for educational and research-reference purposes only. Discussion of experimental, preclinical or clinical findings does not represent a permitted use of Novex Peptide products. Products supplied by Novex Peptide are intended exclusively for in-vitro laboratory research and are not intended for human or animal administration.
Selank is a synthetic heptapeptide derived from the sequence of human immunoglobulin G (IgG). Developed in Russia, it has been studied for its effects on anxiety, immune function, and cognitive processes in animal models.
Mechanism of Action
Anxiolytic Effects
Animal studies suggest Selank may produce anxiolytic effects without the sedation or dependence associated with benzodiazepines. The mechanism may involve modulation of GABAergic neurotransmission.
Immunomodulatory Effects
As a derivative of IgG, Selank has been studied for its effects on immune function, including influences on cytokine production and T-cell activity in animal models.
Enkephalin Degradation
Research indicates Selank may inhibit enzymes that degrade enkephalins (endogenous opioid peptides), potentially influencing pain and stress responses.
Current Research
Anxiety Research
Animal studies using elevated plus maze and open field tests have investigated Selank's anxiolytic properties.
Immune Research
Studies have explored Selank's effects on inflammatory cytokines, antibody production, and immune cell activity in animal models.
Cognitive Research
Some research has investigated Selank's effects on memory, learning, and attention in animal behavioural models.
Chemical Properties
Storage Considerations
Follow the supported product label and compound-specific laboratory protocol. Solution stability depends on the exact material, solvent, concentration and storage conditions; there is no universal refrigerated shelf life or freezing protocol. Obtain missing stability information before preparation. Where validated, use aliquots to minimise repeated freeze-thaw cycles.
Testing Methods
Selank batches should be verified by:
Research Limitations
Selank is supplied for in-vitro laboratory research only. Published preclinical literature includes in-vivo animal studies. References to such studies are provided solely as scientific background and do not indicate that Novex Peptide products are supplied for animal administration. Most published research originates from Russian research groups. No clinical trials outside Russia have confirmed efficacy. No medical, therapeutic, or dosing claims are made. Selank is not approved for human therapeutic use by Western regulatory authorities.
References
- 1.Seredenin SB, et al. Selank Pharmacology. Bull Exp Biol Med. 2008;145(3):328-330.
- 2.Kozlovskaya MM, et al. Selank and Anxiety. Bull Exp Biol Med. 2007;143(4):437-439.
- 3.Zozulya AA, et al. Selank and Immune System. Int J Immunopharmacol. 2001;23(1):47-54.
Research use only. This article is for educational purposes only and does not constitute advice for any application involving human use. No medical claims are made.
